Orabi D

References (1)

Title : The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular Carcinoma - Orabi_2025_bioRxiv__

Author(s) : Orabi D , Massey WJ , Fung KK , Varadharajan V , Ramachandiran I , Banerjee R , Silver DJ , Osborn LJ , Brown AL , Marshall S , Ferguson D , Cao S , Schugar RC , Finney C , Neumann C , Burrows AC , Horak AJ , Pathak P , Helsley RN , Bulfon D , Zimmermann R , Leung YH , Madiraju SRM , Prentki M , Lee RG , Mullick AE , Zergeeva O , Dasarathy S , Lee Z , Allende DS , Aucejo F , Lathia JD , Brown JM

Ref : Biorxiv , : , 2025

Abstract :

PubMedSearch : Orabi_2025_bioRxiv__

PubMedID: 40766524

Orabi D

References (1)

1. The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular Carcinoma - Orabi_2025_bioRxiv__